| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Mar―12 |
Combination of adenovirus vector and subunit protein elicits a robust immune response against the SARS-CoV-2 Omicron variant |
Chunjun Ye, Xiya Huang, Weiqi Hong, Jie Shi, Danyi Ao, Yu Zhang, et al. (+10) Yishan Lu, Yingqiong Zhou, Zhiruo Song, Yu Zhang, Yanyan Liu, Ping Cheng, Guangwen Lu, Jiong Li, Xiangrong Song, Xiawei Wei |
| 2 |
[GO] |
2025―Oct―14 |
Development of a trispecific fusion protein based on angiotensin-converting enzyme 2, glycoprotein 130, and tumor necrosis factor receptor 2 as a promising therapeutic for COVID-19 |
Yongfeng Qiao, Yanjun Han, Lu Zhao, Wenjing Gao, Hong Hu, Chao Su, et al. (+14) Anqi Zheng, Junqing Sun, Mingxiong Tian, Yarong Wu, Lianmei Bai, Yuping Lei, Jiahao Wu, Weibing Zhang, Pu Han, Xiaoyu Li, Chunbo Dong, Haidong Wang, Zhida Liu, Pengcheng Han |
| 3 |
[GO] |
2025―Jan―03 |
The role of artificial intelligence in pandemic responses: from epidemiological modeling to vaccine development |
Mayur Suresh Gawande, Nikita Zade, Praveen Kumar, Swapnil Gundewar, Induni Nayodhara Weerarathna, Prateek Verma |
| 4 |
[GO] |
2024―Dec―05 |
Characteristics of the early innate response induced by the aerosolized Ad5-vectored COVID-19 vaccine |
Wan-Ru Zheng, Jun-Yan Dan, Nan Huo, Zhe Zhang, Li-Hua Hou |
| 5 |
[GO] |
2024―Jul―28 |
Assessing the neutralizing antibody and duration of RNA positivity from COVID-19 infected patients with immunocompromised diseases and pneumonia |
Shuo Liu, Xuelian Wu, Ziteng Liang, Weijin Huang, Yufeng Xiong |
| 6 |
[GO] |
2024―May―17 |
Effects of different treatments for type 2 diabetes mellitus on mortality of coronavirus disease from 2019 to 2021 in China: a multi-institutional retrospective study |
Ke Xu, Wu He, Bo Yu, Kaineng Zhong, Da Zhou, Dao Wen Wang |
| 7 |
[GO] |
2023―Dec―18 |
Correction: Activation and induction of antigen-specific T follicular helper cells play a critical role in recombinant SARS-CoV-2 RBD vaccine-induced humoral responses |
Songhao Yang, Liangwei Duan, Chan Wang, Cuiying Zhang, Siyu Hou, Hao Wang, et al. (+9) Jiahui Song, Tingting Zhang, Zihua Li, Mingxia Wang, Jing Tang, Qianqian Zheng, Hui Wang, Qi Wang, Wei Zhao |
| 8 |
[GO] |
2023―Nov―07 |
SARS-CoV-2 RNA persists in the central nervous system of non-human primates despite clinical recovery |
Hailong Li, Kristen A. McLaurin, Charles F. Mactutus, Jay Rappaport, Prasun K. Datta, Rosemarie M. Booze |
| 9 |
[GO] |
2023―Oct―19 |
Activation and induction of antigen-specific T follicular helper cells play a critical role in recombinant SARS-CoV-2 RBD vaccine-induced humoral responses |
Songhao Yang, Liangwei Duan, Chan Wang, Cuiying Zhang, Siyu Hou, Hao Wang, et al. (+9) Jiahui Song, Tingting Zhang, Zihua Li, Mingxia Wang, Jing Tang, Qianqian Zheng, Hui Wang, Qi Wang, Wei Zhao |
| 10 |
[GO] |
2023―Aug―03 |
Crystal structures of main protease (Mpro) mutants of SARS-CoV-2 variants bound to PF-07304814 |
Haihai Jiang, Xiaofang Zou, Pei Zeng, Xiangyi Zeng, Xuelan Zhou, Jie Wang, et al. (+2) Jin Zhang, Jian Li |
| 11 |
[GO] |
2023―May―22 |
Modular characterization of SARS-CoV-2 nucleocapsid protein domain functions in nucleocapsid-like assembly |
Yan Wang, Xiaobin Ling, Chong Zhang, Jian Zou, Bingnan Luo, Yongbo Luo, et al. (+11) Xinyu Jia, Guowen Jia, Minghua Zhang, Junchao Hu, Ting Liu, Yuanfeiyi Wang, Kefeng Lu, Dan Li, Jinbiao Ma, Cong Liu, Zhaoming Su |
| 12 |
[GO] |
2023―Mar―10 |
Trimeric protein vaccine based on Beta variant elicits robust immune response against BA.4/5-included SARS-CoV-2 Omicron variants |
Cai He, Li Chen, Jingyun Yang, Zimin Chen, Hong Lei, Weiqi Hong, et al. (+7) Xiangrong Song, Li Yang, Jiong Li, Wei Wang, Guobo Shen, Guangwen Lu, Xiawei Wei |
| 13 |
[GO] |
2022―Dec―12 |
Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication |
Tirosh Shapira, Selvarani Vimalanathan, Celine Rens, Virginia Pichler, Sandra Peña-Díaz, Grace Jordana, et al. (+7) William Rees, Dirk F. H. Winkler, Iqbal Sarai, Theodore Steiner, François Jean, Steven Pelech, Yossef Av-Gay |
| 14 |
[GO] |
2022―Nov―28 |
Alterations of the fecal microbiota in relation to acute COVID-19 infection and recovery |
Yue Sandra Yin, Carlos D. Minacapelli, Veenat Parmar, Carolyn C. Catalano, Abhishek Bhurwal, Kapil Gupta, et al. (+2) Vinod K. Rustgi, Martin J. Blaser |
| 15 |
[GO] |
2022―Oct―21 |
Identification of a Sialosides binding pocket in early-lineage SARS-CoV-2 via an optimized STD NMR method: a novel explanation for coronavirus virulence and zoonosis |
Geng Chen, Wei Gao, Yang Du |
| 16 |
[GO] |
2022―Jul―15 |
Significant perspectives on various viral infections targeted antiviral drugs and vaccines including COVID-19 pandemicity |
Gandarvakottai Senthilkumar Arumugam, Kannan Damodharan, Mukesh Doble, Sathiah Thennarasu |
| 17 |
[GO] |
2022―Jul―05 |
A new strategy: identification of specific antibodies for neutralizing epitope on SARS-CoV-2 S protein by LC-MS/MS combined with immune repertoire |
Meng Yu, Zhu Zhu, Yanqun Wang, Pingzhang Wang, Xiaodong Jia, Jie Wang, et al. (+13) Lei Liu, Wanbing Liu, Yaqiong Zheng, Guomei Kou, Weiyan Xu, Jing Huang, Fengmin Lu, Xiajuan Zou, Shangen Zheng, Yinying Lu, Jincun Zhao, Hui Dai, Xiaoyan Qiu |
| 18 |
[GO] |
2022―Jun―02 |
Cleavage of the selective autophagy receptor SQSTM1/p62 by the SARS-CoV-2 main protease NSP5 prevents the autophagic degradation of viral membrane proteins |
Yabin Zhang, Shiyan Liu, Qingjia Xu, Huihui Li, Kefeng Lu |
| 19 |
[GO] |
2022―May―20 |
Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19 |
Shuai Yang, Ying Tong, Lu Chen, Wenqiang Yu |
| 20 |
[GO] |
2022―Apr―24 |
Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies |
Du Guo, Huaichuan Duan, Yan Cheng, Yueteng Wang, Jianping Hu, Hubing Shi |
| 21 |
[GO] |
2022―Feb―17 |
Stem cell therapy for COVID-19 pneumonia |
Maziar Malekzadeh Kebria, Peiman Brouki Milan, Noshad Peyravian, Jafar Kiani, Soheil Khatibi, Masoud Mozafari |
| 22 |
[GO] |
2021―Nov―23 |
Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target? |
Kavya Srinivasan, Ashutosh Kumar Pandey, Ashlena Livingston, Sundararajan Venkatesh |
| 23 |
[GO] |
2021―Sep―29 |
A promising vaccine candidate against COVID-19 |
Xiwei Wang, Wenwei Tu |
| 24 |
[GO] |
2021―Sep―26 |
Fast and long-lasting immune response to S-trimer COVID-19 vaccine adjuvanted by PIKA |
Yuan Liu, Lianpan Dai, Xiaoli Feng, Ran Gao, Nan Zhang, Bin Wang, et al. (+9) Jianbao Han, Qingcui Zou, Xiling Guo, Hua Zhu, Jiangning Liu, Chuan Qin, Yi Zhang, Linlin Bao, Minghua Li |
| 25 |
[GO] |
2021―Sep―19 |
Computationally repurposed drugs and natural products against RNA dependent RNA polymerase as potential COVID-19 therapies |
Sakshi Piplani, Puneet Kumar Singh, David A. Winkler, Nikolai Petrovsky |
| 26 |
[GO] |
2021―Apr―09 |
COVID-19: insights into virus-receptor interactions |
Azadeh Sepahvandi, Maryam Ghaffari, Amir Hossein Bahmanpour, Fathollah Moztarzadeh, Payam Zarrintaj, Hasan Uludağ, Masoud Mozafari |
| 27 |
[GO] |
2021―Mar―20 |
Disruption of respiratory epithelial basement membrane in COVID-19 patients |
Xue Liu, Yinshan Fang, Paul W. Noble, Jianwen Que, Dianhua Jiang |
| 28 |
[GO] |
2021―Jan―20 |
Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19 |
Yanghong Ni, Aqu Alu, Hong Lei, Yang Wang, Min Wu, Xiawei Wei |
| 29 |
[GO] |
2020―Dec―03 |
Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines |
Yinan Xiao, Hanyue Xu, Wen Guo, Yunuo Zhao, Yuling Luo, Ming Wang, et al. (+6) Zhiyao He, Zhenyu Ding, Jiyan Liu, Lei Deng, Fushen Sha, Xuelei Ma |
| 30 |
[GO] |
2020―Nov―20 |
SARS-CoV-2 is less likely to infect aquatic food animals: sequence and phylogeny analysis of ACE2 in mammals and fish |
Dong Chen, Yuchen Liu, Huihui Yang, Lisa Liu, Weiren Huang, Yongsheng Zhao |
| 31 |
[GO] |
2020―Aug―19 |
Structural basis for the multimerization of nonstructural protein nsp9 from SARS-CoV-2 |
Changhui Zhang, Yiping Chen, Li Li, Yan Yang, Jun He, Cheng Chen, Dan Su |
| 32 |
[GO] |
2020―Aug―06 |
Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein |
Renjie Zhou, Rui Zeng, Albrecht von Brunn, Jian Lei |